Intravitreal Combined Aflibercept + Anti–Platelet-Derived Growth Factor Receptor β for Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Intravitreal Combined Aflibercept + Anti–Platelet-Derived Growth Factor Receptor β for Neovascular Age-Related Macular Degeneration

Published:2020-02 Issue:2 Volume:127 Page:211-220
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Heier Jeffrey S.^ORCID,Wykoff Charles C.^ORCID,Waheed Nadia K.,Kitchens John W.,Patel Sunil S.,Vitti Robert,Perlee Lorah^ORCID,Chu Karen W.^ORCID,Leal Sergio^ORCID,Asmus Friedrich,Son Vladimir^ORCID,Schmelter Thomas,Brown David M.^ORCID

Funder

Bayer HealthCare

Regeneron Pharmaceuticals

Publisher

Elsevier BV

Subject

Ophthalmology

Reference15 articles.

1. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration;Heier;Ophthalmology,2012

2. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies;Schmidt-Erfurth;Ophthalmology,2014

3. A meta-analysis of studies evaluating visual and anatomical outcomes in patients with treatment resistant neovascular age-related macular degeneration following switching to treatment with aflibercept;Seguin-Greenstein;J Ophthalmol,2016

4. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study;Brown;Ophthalmology,2009

5. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-year efficacy and safety of different anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: a network meta-analysis of randomized controlled trials;Eye;2024-09-11

2. Aqueous humor cytokine levels in patients with subretinal fibrosis in neovascular age-related macular degeneration;BMC Ophthalmology;2024-08-12

3. Mechanisms of Acquired Resistance to Anti-VEGF Therapy for Neovascular Eye Diseases;Investigative Opthalmology & Visual Science;2023-05-30

4. Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model;Translational Vision Science & Technology;2023-05-23

5. Rethinking the potential and necessity of drug delivery systems in neovascular age-related macular degeneration therapy;Frontiers in Bioengineering and Biotechnology;2023-05-23